It was a banner week for U.S. stocks as the S&P 500 jumped 2.4%. Buoyed by Google’s (NasdaqGS: GOOG) Friday surge, one that saw the company at one point add over $60 billion in market value, the Nasdaq Composite finished Friday at a record high.
Forty-three exchange traded funds hit all-time highs on Friday. Underscoring the ongoing strength in the healthcare sector, 10 of those funds were healthcare, pharmaceuticals or biotech ETF. Speaking of, there are some healthcare-related articles in this week’s rendition of big ETF stories of the week.
Broad Market/Sector ETFs
Why this biotech ETF keeps surging. [This Biotech ETF is on Fire]
Some good reasons to consider homebuilders ETFs right now.
Amazon rally is a prime deal for consumer discretionary ETFs.
Traders are flocking to leveraged biotech ETFs. [Leveraged Biotech ETFs Haul in Cash]
IPO ETFs dodge some of the weakest new issues. [IPO ETFs Skimp on Weak new Issues]